Who is Regenerative Tissue Science?

A nutritional pioneer founded on the medical advances of regenerative sciences, dedicated to innovations in adult stem cells of structural and connective tissues stimulation to achieve and maintain healthier function.

We provide the only scientifically proven and patented, adult stem cell stimulating proteins, in the convenience of a daily supplement.

Every product and service we provide is designed to help the more then 110 million adults in the US experiencing bone, joint & muscle health issues or the 90 million with great bone & joint health who want to maintain an active lifestyle.

The Regenerative Tissue Science Difference – Research, Manufacturing and Sales all in one vertically integrated organization

Regenerative Tissue Science, LLC is the marketing and distribution division of ZyCal Bioceuticals Healthcare Company – a global leader in Natural, Bone, Joint & Muscle Health.

A research, development, and manufacturing company providing cutting-edge nutritional products containing Cyplexinol® focused on Musculoskeletal Regenerative Health. ZyCal Bioceuticals Healthcare Company conducts bone and joint clinical research, offering educational programs for healthcare professionals, their patients, and consumers alike.

Cyplexinol® is produced from natural and certified organic bovine bone sourced in partnership with small, premier mid-western cattle ranchers operating under strict closed herd protocols to provide the most premium sourced nutritional ingredient.

Supplement and pharmaceutical companies around the globe license and sell Cyplexinol®-containing products (except Ostinol), into the Far East, Africa, and Europe, making Cyplexinol® a global leading ingredient in Musculoskeletal Regenerative Nutrition.

EFFICACY & PURITY TEST - ABOVE & BEYOND INDUSTRY STANDARDS

Regenerative Tissue Science, LLC is committed to providing Musculoskeletal Regenerative Nutritional solutions that stand above the industry and go the extra mile by testing each and every batch of Cyplexinol® ingredient to assure safety, purity, and efficacy.

Every batch of Cyplexinol® -Nature’s BMP-Complex, the Bone and Cartilage Stimulating Proteins in Ostinol®, undergoes an array of testing, by Independent Labs before release. Testing includes safety and purity, ensuring no microbiological or heavy metals contamination, as well as over 30 nutritional chemistry tests for batch confirmation and concentrations.

Each batch of Cyplexinol® is then subjected to the same rigorous in vivo "gold standard" performance testing as orthopedic surgical companies, a 45-day live animal tissue assay. This testing, scientifically proves every batch of Cyplexinol® stimulates, activates and differentiates stem cells into osteoblasts (bone building cells) and chondrocytes (cartilage-building cells) which produce de novo (new) bone and cartilage tissue.

NO OTHER NUTRITIONAL SUPPLEMENT COMPANY CAN MAKE THIS CLAIM, PUTTING CYPLEXINOL® IN A CLASS OF ITS OWN!

Manufactured in an FDA registered facility under cGMP guidelines

  • 100% Natural protein-complex
  • Made in the USA
  • Sourced from USDA Certified bovine bone, from premier cattle ranchers operating under strict closed herd protocols
  • Gluten-Free, Grain-Free– No wheat, corn, or soy
  • GMO free

OUR GUARANTEE

Your Comfort & Satisfaction is our mission – 100% Guaranteed!

Regenerative Tissue Science, LLC stands behind a commitment of your complete satisfaction. If you have a question, please call 888-779-9225 and speak to one of our Regenerative Nutrition Team members to address your concerns. If, for any reason, you are not satisfied, your purchase price and shipping will be fully refunded, and you can even keep the bottle – no questions asked.

Guarantee is limited to one replacement bottle per customer purchased directly from Regenerative Tissue Science, LLC or an Authorized Amazon distributor. If purchased from a healthcare professional, a refund will be made through your doctor, or at the discretion of Regenerative Tissue Science, LLC.

Regenerative Tissue Science, LLC is a world leader Musculoskeletal Regenerative Nutrition and the marketer and distributor of Ostinol® Bone and Cartilage Stimulating Proteins. Led by a best-in-class team, we offer premium nutritional supplements, resources, and support. From our Scientific Advisory Board consisting of leaders in Regenerative Medicine & Orthopedics Surgery, to our Regenerative Nutrition Team and The Ostinol® Community, we've started a movement that offers unmatched resources and expert advice for people at every stage of their bone, joint and muscle health journey.


BOARD OF DIRECTORS

JAMES HOBBS, MBA
CHAIRMAN

James Hobbs is a senior executive with over thirty years of experience in the healthcare, diagnostic and medical device industry. His business background demonstrates a successful track record starting up and managing companies, commercialization of innovative medical technologies.

Mr. Hobbs received is currently Chairman of the Board at ZyCal Bioceuticals Healthcare Company, Inc., a Managing Partner at Graylyn Associates, Inc. He was also a Principal at Parametrics Medical – Orthobiologics and regenerative medicine, providing the latest advancements in allograft tissue, biologic implants, and regenerative medicine designed to enhance surgical outcomes and improve patient quality of life. Prior, Mr. Hobbs was President of Johnson and Johnson Diagnostic before he launched Geneca Diagnostic as its first CEO, which became the premier neurological diagnostic company now owned by Quest Diagnostics.

JAMES J. SCAFFIDI, D.N.M.C., B.SC
CEO & PRESIDENT

James J. Scaffidi is CEO & President of ZyCal Bioceuticals, holds a degree in Biochemistry, with 3 years of graduate-level research in enzymology and protein purification, has published several peer-reviewed clinical studies and trials, and is currently completing his doctorate in natural medicine.

James has 30 years of sales, marketing and management experience in pharmaceuticals, diagnostic and allograft tissue business for the repair and healing of the musculoskeletal system, biologic products for regenerative healing.

Prior to launching ZyCal James held a senior management position in a spine biomechanical company serving as Marketing Director as well as the Medical Writer for Dr. Manohar Panjabi from Yale School of Medicine, an inventor and expert in spine biomechanics.

DR. HYUN D. KIM, PHD

Dr. Kim received his Pd.D. in Medical Science, completing a thesis on Polymeric delivery systems and scaffolds for bone growth and morphogenic factors from Brown University, and his masters and undergraduate studies focused on Biomedical Engineering.

Dr. Kim brings scientific expertise in therapeutic areas of regenerative medicine (PRP & DMB), orthopedics (bone, cartilage, tendon repair, osteoporosis) inflammation (arthritis) and neurology. He has managed the preclinical/clinical development and participated in Phase I-III meetings with the FDA.

Dr. Kim has led multiple teams in development focusing on regenerative therapies that include:

  • Headed product development of musculoskeletal (orthopedic, anti-inflammatory) peptide and protein delivery for treating osteoarthritis and cartilage repair.
  • Developing protein-small molecule conjugates and PEGylated proteins as systemic targeted therapy for osteoporosis.
  • Injectable fracture repair resulting in IND filing for BMP-2 injectable fracture repair, including injectable proteins and delivery systems for local osteoporosis therapy and tendon repair (BMP-2 and BMP-12).
  • Injectable and implantable biomaterials and delivery systems for BMP proteins involved in bone and cartilage repair.

-EMERITUS-
DANIEL TRIPODI, PHD.
(IN MEMORY OF) 1939 - 2020

Dr. Tripodi was an essential contributor and Board of Directors member realizing the potential of Cyplexinol®, as an oral Bone and Cartilage Stimulating Protein supplement.

He held a PhD in Immunochemistry from Temple University.

During his 20 years with Johnson & Johnson, he held various senior positions in Technological and Strategic Planning including the Director of Biotechnology.

Served on Scientific Advisory Boards of the State University of New York at Stony Brook and the University of Utah, as well as the Biotechnology Advisory Committee for the Department of Commerce and Vice Chairman of the NJ Commission on Cancer Research (Governor's Panel).

Dr. Tripodi served as Vice President of Research and Development at Thera Kos, developer of photopheresis device UVAR. He has published extensively in the fields of immunochemistry and immunology, and holds several patents, for both drugs and devices.


SCIENTIFIC & MEDICAL ADVISORY BOARD

Regenerative Tissue Science, LLC has enlisted the guidance of the health industry’s leading experts in musculoskeletal regenerative health to form our exclusive Scientific Advisory Board! The board is composed of doctors, academics, authors, and innovators at the forefront of regenerative innovation.

As board members, they help guide decision-making on Ostinol®, and provide the latest information to aid people on their bone-health journey.

We partner with the world's leading musculoskeletal regenerative health scientists.

DR. HYUN D. KIM, PHD

Dr. Kim received his Pd.D. in Medical Science, completing a thesis on Polymeric delivery systems and scaffolds for bone growth and morphogenic factors from Brown University, and his masters and undergraduate studies focused on Biomedical Engineering.

Dr. Kim brings scientific expertise in therapeutic areas of regenerative medicine (PRP & DMB), orthopedics (bone, cartilage, tendon repair, osteoporosis) inflammation (arthritis) and neurology. He has managed the preclinical/clinical development and participated in Phase I-III meetings with the FDA.

Dr. Kim has led multiple teams in development focusing on regenerative therapies that include:

  • Headed product development of musculoskeletal (orthopedic, anti-inflammatory) peptide and protein delivery for treating osteoarthritis and cartilage repair.
  • Developing protein-small molecule conjugates and PEGylated proteins as systemic targeted therapy for osteoporosis.
  • Injectable fracture repair resulting in IND filing for BMP-2 injectable fracture repair, including injectable proteins and delivery systems for local osteoporosis therapy and tendon repair (BMP-2 and BMP-12).
  • Injectable and implantable biomaterials and delivery systems for BMP proteins involved in bone and cartilage repair.

WILLIAM FRANKE, PHD

Dr. Franke was the Vice President of Research, Development, Quality and Regulatory Affairs at Unilever/Lipton corporation.

Dr. Franke later went to become the Director of the Center for Advanced Foods at Rutgers University and is an expert in product development and food regulations, with a specialty in functional foods and nutraceuticals.

He is a co-principal investigator for a U.S. Department of Defense contractor to develop combat rations to improve the physical and mental performance of soldiers under stress. Featured in Use of Dietary Supplements published by Institute of Medicine of the national Academies.

He is a former member of the NAS/IOM Food Forum and served on the IOM expert Committee on Evaluation of the Addition of Ingredients New to Infant Formula. He also served as a member of the board of the Cancer Institute of New Jersey and was recently elected a Fellow of the Institute of Food Technologists.

Dr. Franke founded Heart Blend Foods, LLC, research, and development company specializing heart-healthy foods.

ADAM PERLMAN, MD

As the CEO and co-founder of Journey, Dr. Perlman is developing the next generation of wellbeing centers.

The former Associate VP of Health & Wellness for The Duke University Health System, he is currently an adjunct professor at Duke University School of Medicine and Director of their Leadership Program in Integrative Healthcare.

Dr. Pearlman is also the past Chair of Academic Consortium for Integrative Medicine and Health, comprised of over 75 leading academic medical centers around the country.

Dr. Perlman received his MD from Boston University School of Medicine and earned an MPH from the Boston University School of Public Health.

DUSTIN MOFFITT, ND

Dr. Moffitt is the Regenerative Medicine Specialist of the renowned Riordan Clinic, and Medical Director of the Hays, Kansas location. A Naturopathic Doctor with advanced certifications in Bioidentical hormones, thyroid replacement, IV nutrition, and Prolotherapy needling; specializing in pain management, sports rehabilitation, chronic illness, hormone therapies, thyroid management, and weight loss.

Dr. Moffitt is a native Kansan, earning his bachelor’s degree at Wichita State University with a major in chemistry and minors in biology, physics, and sociology. He received his Doctor of Naturopathic Medicine from the National College of Natural Medicine (NCNM) – now known as National University of Natural Medicine — in Portland, Oregon where he also spent five years teaching nutrition and wellness at the Food as Medicine Institute in Portland.


At the core of Regenerative Tissue Science, LLC

Regenerative Tissue Sciences LLC, marketer, and distributor of Ostinol®, offers unparalleled customer service. Our Regenerative Nutrition Team members are available 5-days a week to answer any questions customers, patients or consumers may have about their bone, joints, or other musculoskeletal needs. A completely free service for anyone who wants to "Stand Tall with Ostinol" in every step of their bone, joint and muscle health journey.

Please call our knowledgeable team members at 1.888.779.9225 or email them at support@regenerativetissuescience.com to discuss any questions or concerns you may have.


Health Care Professionals

Regenerative Tissue Science, LLC provides health care professionals a natural option to support their patients' musculoskeletal health through every stage of life and every challenge they face.

Patients are increasingly seeking treatment from doctors and other functional and integrative medicine specialists, such as Functional MDs, Naturopathic Physicians, dietitians, nutritionists, and more.

Through Regenerative Tissue Science, LLC HCP, forward-thinking practitioners can offer their patients direct access to the best, all-natural solution of regenerative nutrition for musculoskeletal health.

* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.